Cancer and hematology Immunotherapy minimizes cancer recurrence risk for Merkel cell carcinoma patient
Cancer and hematology Combination therapy offers hope for melanoma patients facing recurrence A melanoma diagnosis can be scary, but when it’s caught and treated early, the estimated five-year survival rate in the U.S. is about 99%. But what if your melanoma is one of the rare melanomas to
Cancer and hematology How multidisciplinary cancer treatment is changing the outlook on pancreatic cancer
Press release HonorHealth Scottsdale Shea Medical Center is first hospital in Arizona to perform revolutionary, minimally invasive robotic lung biopsy procedures